BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 16209291)

  • 1. [Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma].
    Kovrigina AM; Probatova NA
    Arkh Patol; 2005; 67(4):10-6. PubMed ID: 16209291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell rich B-cell lymphoma--a case report.
    Pai RR; Khadilkar UN; Pai MR; Dinesh M
    Indian J Pathol Microbiol; 2003 Jul; 46(3):427-8. PubMed ID: 15025291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distinction of Hodgkin's disease from B cell lymphoma.
    Warnke RA
    Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
    Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
    Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma).
    Rüdiger T; Jaffe ES; Delsol G; deWolf-Peeters C; Gascoyne RD; Georgii A; Harris NL; Kadin ME; MacLennan KA; Poppema S; Stein H; Weiss LE; Müller-Hermelink HK
    Ann Oncol; 1998; 9 Suppl 5():S31-8. PubMed ID: 9926235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of L26-positive, CD15-negative Hodgkin's disease and large B-cell lymphoma with a high content of reactive T-cells: a morphologic and immunohistochemical study.
    Nguyen DT; Diamond LW; Hansmann ML; Fischer R
    Hematopathol Mol Hematol; 1996; 10(3):135-50. PubMed ID: 8878732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.
    Treetipsatit J; Metcalf RA; Warnke RA; Natkunam Y
    Hum Pathol; 2015 Jan; 46(1):74-83. PubMed ID: 25456392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
    Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
    Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large B-cell lymphoma with Hodgkin's features.
    García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
    Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
    Churchill HR; Roncador G; Warnke RA; Natkunam Y
    Hum Pathol; 2010 Dec; 41(12):1726-34. PubMed ID: 20825974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
    Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
    Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
    Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse large B-cell lymphoma and its variants.
    Dominis M; Dzebro S; Gasparov S; Pesut A; Kusec R
    Croat Med J; 2002 Oct; 43(5):535-40. PubMed ID: 12402391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
    Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
    Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hodgkin lymphoma with lymphoid predominance: differential diagnosis of nodular lymphoid predominance and classical variant].
    Kovrigina AM; Probatova NA; Pavlovskaia AI; Tupitsyn NN; Sholokhova EN; Tumian GS
    Arkh Patol; 2003; 65(4):3-8. PubMed ID: 14518185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease.
    Chittal SM; Brousset P; Voigt JJ; Delsol G
    Histopathology; 1991 Sep; 19(3):211-20. PubMed ID: 1655614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell rich and histiocyte rich B cell lymphoma--a case report.
    Rajwanshi A; Banerjee AK; Chawla YK
    Indian J Pathol Microbiol; 1997 Jan; 40(1):85-9. PubMed ID: 9145621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
    Schmidt U; Herbst J; Metz KA; Leder LD
    J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.